SAN MATEO, CA, WithMe Health, a medication guidance company, today announced the closing of a Series B financing round of $20 million.
The round was led by OMERS Ventures and with participation from existing investor Oak HC/FT, along with new investors Section 32, Shulman Ventures and MTS Ventures. Michael Yang, Managing Partner of OMERS Ventures, will join WithMe Health's Board of Directors and Brian Marcotte, past CEO and President of the Business Group on Health, will join the Advisory Board. Coupled with recent partnerships with Centivo and Consociate Health, the new funding will support further growth of the client base as well as an extension of the core offering.
WithMe Health was founded on the belief that improved health outcomes and lower total cost of care can be achieved through better medication guidance. Their personalized medication guidance solution tailors medication selection to the individual and guides members through every step of their medication journey. The company is headquartered in Silicon Valley and has raised $40 million. Follow WithMe Health on Twitter and LinkedIn. https://www.withmehealth.com/
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about